Changes in Antioxidant Enzyme Activity and Malondialdehyde Level in Patients with Age-Related Macular Degeneration
- 28 April 2004
- journal article
- Published by S. Karger AG in Ophthalmologica
- Vol. 218 (3), 202-206
- https://doi.org/10.1159/000076845
Abstract
Age-related macular degeneration is the leading cause of legal blindness in the developed world, and yet its pathogenesis remains poorly understood. Oxidative stress may play a major role in the etiology and pathogenesis of age-related disorders such as age-related macular degeneration. Catalase is an antioxidant enzyme which plays an important role in the detoxification of free oxygen radicals. Malondialdehyde is a marker that shows free radical damage. We have measured the erythrocyte activity of catalase and the serum level of malondialdehyde in 30 patients with age-related macular degeneration and 60 healthy subjects. Patients with age-related macular degeneration showed significantly lower catalase activity compared to healthy subjects (p = 0.002). Plasma malondialdehyde level of the patient group was significantly higher than that of the controls (p = 0.038).Keywords
This publication has 7 references indexed in Scilit:
- Plasma malondialdehyde and nitric oxide levels in age related macular degenerationBritish Journal of Ophthalmology, 2001
- Antioxidant enzymes in the macular retinal pigment epithelium of eyes with neovascular age-related macular degenerationAmerican Journal of Ophthalmology, 1999
- Associations of antioxidant enzymes with cataract and age-related macular degenerationOphthalmology, 1999
- Blue Light-induced Reactivity of Retinal Age PigmentJournal of Biological Chemistry, 1995
- Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study GroupPublished by American Medical Association (AMA) ,1994
- Age-related macular degenerationSurvey of Ophthalmology, 1988
- Solar radiation and age-related macular degenerationSurvey of Ophthalmology, 1988